Literature DB >> 8635273

Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women.

V Guetta1, R O Cannon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8635273     DOI： 10.1161/01.cir.93.10.1928

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  31 in total

Review 1.  Postmenopausal hormone therapy, SERMs, and coronary heart disease in women.

Authors:  N K Wenger; D Grady
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

Review 2.  Molecular mechanisms of estrogen actions on the vasculature.

Authors:  M P Haynes; K S Russell; J R Bender
Journal:  J Nucl Cardiol       Date:  2000 Sep-Oct       Impact factor: 5.952

Review 3.  Hormone replacement therapy and cardiovascular risk.

Authors:  M Gerhard-Herman; N Hamburg; P Ganz
Journal:  Curr Cardiol Rep       Date:  2000-07       Impact factor: 2.931

4.  Serum lipid profiles, the prevalence of dyslipidemia and the risk factors in two isolated Chinese minorities.

Authors:  Pei-Juan Liao; Rui-Bin Xie; Rui-Xing Yin; Dai-Xun Wei; Jian Huang; Feng Huang; Hui Li; Wei-Xiong Lin; Jin-Zhen Wu; Shang-Ling Pan
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 5.  COVID-19 in Africa: an ovarian victory?

Authors:  Osman A Dufailu; Afrakoma Afriyie-Asante; Bernard Gyan; David Adu Kwabena; Helena Yeboah; Frank Ntiakoh; Meshach Asare-Werehene
Journal:  J Ovarian Res       Date:  2021-05-21       Impact factor: 4.234

Review 6.  Management of lipid disorders in the elderly.

Authors:  D A Playford; G F Watts
Journal:  Drugs Aging       Date:  1997-06       Impact factor: 3.923

7.  Phytoestrogen alpha-zearalanol inhibits atherogenesis and improves lipid profile in ovariectomized cholesterol-fed rabbits.

Authors:  Shunling Dai; Jinhong Duan; Yuan Lu; Yihua Zhang; Jinxuan Cheng; Jun Ren; Xiaoyuan Zhao; Yunqing Wu; Yue Yu; Pingping Zuo; Yiyong Wu; Qinsheng Ge
Journal:  Endocrine       Date:  2004-11       Impact factor: 3.633

8.  Exemestane Use in Postmenopausal Women at High Risk for Invasive Breast Cancer: Evaluating Biomarkers of Efficacy and Safety.

Authors:  Margaret E Gatti-Mays; David Venzon; Claudia E Galbo; Andrea Singer; James Reynolds; Erini Makariou; Bhaskar Kallakury; Brandy M Heckman-Stoddard; Larissa Korde; Claudine Isaacs; Robert Warren; Ann Gallagher; Jennifer Eng-Wong
Journal:  Cancer Prev Res (Phila)       Date:  2016-01-12

9.  Phytoestrogen alpha-zearalanol antagonizes oxidized LDL-induced inhibition of nitric oxide production and stimulation of endothelin-1 release in human umbilical vein endothelial cells.

Authors:  Hai-Shan Xu; Jinhong Duan; Shunling Dai; Yunqing Wu; Renyu Sun; Jun Ren
Journal:  Endocrine       Date:  2004-12       Impact factor: 3.633

10.  N(epsilon)-(Carboxymethyl)lysine and Coronary Atherosclerosis-Associated Low Density Lipoprotein Abnormalities in Type 2 Diabetes: Current Status.

Authors:  Khaled A Ahmed; Sekaran Muniandy; Ikram S Ismail
Journal:  J Clin Biochem Nutr       Date:  2008-12-27       Impact factor: 3.114
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.